Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Moderate to Severe Glabellar Lines [Phase 3]

View source ↗

Summary

A Phase 3 study comparing Neuronox and Botox for moderate to severe glabellar lines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Lines

Drugs mentioned

• Botox (OnabotulinumtoxinA)
• Neuronox (botulinum toxin type A)

Snippet

Sponsor: Medy-Tox | Conditions: Glabellar Lines | Phase 3 | Status: COMPLETED